HomeAPLS • NASDAQ
add
Apellis Pharmaceuticals Inc
Previous close
$16.36
Day range
$16.34 - $17.79
Year range
$16.10 - $43.99
Market cap
2.19B USD
Avg Volume
2.89M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 166.80M | -3.21% |
Operating expense | 129.34M | -0.12% |
Net income | -92.22M | -38.84% |
Net profit margin | -55.29 | -43.42% |
Earnings per share | -0.74 | -37.04% |
EBITDA | -82.88M | -34.45% |
Effective tax rate | -0.37% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 362.34M | 8.63% |
Total assets | 807.28M | -2.96% |
Total liabilities | 643.07M | 13.77% |
Total equity | 164.22M | — |
Shares outstanding | 125.68M | — |
Price to book | 12.49 | — |
Return on assets | -24.62% | — |
Return on capital | -31.28% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -92.22M | -38.84% |
Cash from operations | -53.41M | 59.84% |
Cash from investing | -8.00K | 97.27% |
Cash from financing | 274.00K | -99.75% |
Net change in cash | -52.78M | -108.86% |
Free cash flow | -30.47M | 72.74% |
About
Founded
2009
Headquarters
Website
Employees
708
